Navigation Links
Cancer Patients in New South Wales to Receive Advanced Image Guided Radiation Therapy Treatments

North Coast Cancer Institute (NCCI) Coffs Harbour and Port Macquarie began providing radiotherapy treatment services for the first time in the North Coast region of New South Wales, Australia .

Cancer patients in New South Wales now have access to state-of-the-art treatments as the latest in image-guided radiation therapy ( IGRT) equipment from Elekta went clinical at both sites. The first treatment was a major step for a small centre introducing complex treatment technologies such as IMRT and IGRT on an Elekta Synergy(R) system advanced digital linear accelerator, supported by IMPAC MOSAIQ(TM) Oncology information system. The first patient treated had intermediate risk prostate cancer and was planned with MRI-CT fusion and fiducial marker insertion, and treated with dose-escalated 7-field IMRT with online cone-beam CT and electronic portal image verification.

"As a result of the technology now available at the NCCI, we will be able to provide patients with the most modern, highest quality radiation oncology treatment available in Australia," said Area Director of Cancer Services A. Prof. Tom Shakespeare. "What's really exciting is seeing this ground-breaking technology made available to smaller regional centres that have, until now, had no local access to radiotherapy. Even more impressive, is the fact that our team has been able to implement complex Intensity Modulated Radiotherapy Treatment modalities and adopt image guided treatment techniques from the start. This was accomplished in order to offer patients the highest possible quality of care. With the incredible support provided by Elekta, Coffs Harbour has evolved from a city without radiotherapy to a city with the highest quality radiotherapy in the region and our Port Macquarie centre also will start soon, offering the same impressive treatment capabilities. It is not surprising that we are now receiving referrals from across the state and even interstate."

Elekta Sy nergy was selected for the NCCI following a competitive tender process and is considered the market-leading IGRT solution, revolutionizing radiotherapy by offering integrated 3D volumetric imaging at the time of treatment. By imaging patients in the treatment position during the actual time of treatment, Elekta Synergy is able to offer significantly greater treatment accuracy and higher confidence that the intended therapeutic dose is delivered to the patient as planned.


'"/>




Related medicine news :

1. Fibroids unlikely to Turn Cancerous
2. Virus Level could Predict Cervical Cancer Risk
3. Cancer Doctors Okays Controversial Prostate Therapy
4. Potential New Cancer Gene Identified
5. Consensus on "Combination Therapy" for Breast Cancer
6. Cancers of Colon & Rectum linked to Cigarette Smoking
7. Life Saving Cancer Drugs – From Chicken! Possible Says Dolly’ Creatos
8. The Cancer Rumour mill working over time
9. Cancer drugs in development nearly doubled since 1995
10. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
11. Cancer patients turning to Internet for information
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/5/2016)... Seattle, WA (PRWEB) , ... February 05, 2016 ... ... consulting firm, ranked #3 in the 2015 Best in KLAS: Software & Services ... The annual Best in KLAS report independently ranks vendor performance by healthcare ...
(Date:2/5/2016)... ... , ... Stuart Bentkover, MD, FACS is thrilled to announce the ... effective tattoo removal today, Dr. Bentkover is the only doctor in Central Massachusetts to ... has been approved by the Food and Drug Administration (FDA) as a safe and ...
(Date:2/5/2016)... ... ... In sleep, when the defenses of the day are at rest, rejected emotions ... disorders is significant self-criticism, and consequently these patients experience this disease with their feelings, ... for coping with this unease, but also leads to a reservoir of emotions that ...
(Date:2/5/2016)... Ramsey, NJ (PRWEB) , ... February 05, 2016 ... ... Optimizing Primary Care for Patients with Rare Diseases, a continuing medical education (CME) ... conference is the first of its kind—and a first for ACCORD, whose mission ...
(Date:2/5/2016)... ... 2016 , ... –This week, Atascadero water heater company First Call Plumbing ... To view the report, click here or see below. , There ... pros and cons, the type chosen is almost entirely up to personal preference. However, ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... France , Germany , Italy ... ). It includes a 10-year epidemiology forecast for the total prevalent ... sex in these markets. GD epidemiology report is written and developed by ... and market-driven, providing expert analysis of disease trends in the 7MM. ... Italy , Spain , UK, and ...
(Date:2/4/2016)... 2016  The Senior Care Pharmacy Coalition (SCPC) ... Chairman Jason Chaffetz (R-UT) and Ranking ... hearing , "Developments in the Prescription Drug Market," ... questions about abusive pharmacy benefit manager (PBM) pricing ... Ranking Member Elijah Cummings (D-MD) are diligent, serious ...
(Date:2/4/2016)... , Feb. 4, 2016 Wegener ... Global Markets Direct,s, ,Wegener Polyangiitis - Pipeline ... Wegener Polyangiitis,s therapeutic pipeline. This report provides ... Polyangiitis, complete with comparative analysis at various stages, ... (MoA), route of administration (RoA) and molecule type, ...
Breaking Medicine Technology: